The Thymus as a Key Target for Aging Intervention – Dr. Greg Fahy – EARD 2022
This is the followup trial to the first trial which reported epigenetic age reversement for 2.5 years. It has some interesting patient reports about their feelings and how it changed them. I sent Fahy an email after the first trial to ask if I was eligible for this, but I had IBS and he said I would be disqualified.
Dr. Greg Fahy provides an update on the TRIIM X clinical trial during EARD 2022.
The TRIIMX clinical trial aims at understanding how to create a customized thymus-regeneration regimen. Researchers hope that by regenerating thymus they can prevent or reverse some aspects of immune system ageing.
Follow us
##########################
https://www.lifespan.io.
https://www.facebook.com/lifespanio.
https://www.instagram.com/lifespan.io/
##########################
Dr. Fahy has a Bachelor of Science in Biology from University of California at Irvine, and a PhD from Medical College of Georgia. Dr. Fahy was the former Head of the Transfusion and Cryopreservation Program of the U.S. Naval Medical Research Institute, Bethesda Maryland, was where Dr. Fahy developed the first concept of ice-blocking agents.
Dr. Fahy, Chief Scientific Officer of Intervene Immune and Co-Founder, is a biotech firm that specializes in rejuvenation of immune systems, especially the thymus. He led and designed the TRIIM study, published the first report on thymus regrowth in a human normal, and was granted patents for methods and applications of thymus regrowth. Dr. Fahy, who is now the Chief Scientific Officer and Executive Director of 21st Century Medicine in New York, pioneered cryopreservation through vitrification. He also invented a computer program to apply the technology to organs.
Dr. Fahy, who is a biogerontologist as well, is the author and editor-in-chief of The Future of Aging : Pathways to the Extension of Human Life. This book is a collaboration of many authors about the future of Biogerontology.
Dr. Fahy served as a director of the American Aging Association for 16 years and as editor of AGE News (the organization’s magazine) for six years. He is currently on the editorial board of Rejuvenation Research as well as the Open Geriatric Medicine Journal.
The annual Ending Age-Related Diseases Conference by Lifespan.io brings longevity thought leaders to share research reports, get inspired and find new ideas. They also look for collaborators, sponsors, and mentors.
Source:
